A parallel decline in the expression of the MyoD nuclear transcription supports a significant role of transcriptional

regulation of myosin synthesis in this type of muscle wasting (4). In the rodent cancer model, the myosin loss was not associated with a decrease in myosin mRNA levels, and the myosin loss was primarily related to an enhanced activation of the ubiquitin ligase-dependent proteasome pathway (4). Numerous cytokines, including TNF-α, IL-1, IL-6 and IL-8, are up-regulated by the NFκB transcriptional factor and Kawamura and coworkers have shown in experimental animal models that blocking NFκB inhibits cancer cachexia, without affecting tumor growth (5, 6). The primary aim of Inhibitors,research,lifescience,medical this study is to improve our understanding of Inhibitors,research,lifescience,medical the mechanisms underlying muscle paralysis and muscle wasting in a patient with cancer cachexia, with specific reference to myosin gene and protein expression, and the concomitant effects on regulation of muscle contraction at the single fiber level. It is hypothesized that the severe muscle weakness and loss of muscle mass associated with cancer cachexia is secondary to a preferential loss of myosin. Clinical history Patient A 63 year-old man presented

with a 6-month history of dyspnoea and was diagnosed to suffer from a small cell lung carcinoma and mild type 2 diabetes. Approximately 3 months Inhibitors,research,lifescience,medical after being diagnosed with lung cancer, electromyography (EMG), electroneurography (ENeG) and muscle biopsy was performed due to rapid muscle wasting, loss of muscle function and areflexia in the lower extremities. During this 9 month period, the patient had not been exposed to mechanical Inhibitors,research,lifescience,medical ventilation or non-depolarizing neuromuscular blocking agents. The patient was only given a single 1 ml i.v. dose of corticosteroids during the complete observation period. The electroneurography (ENeG)

and electromyography (EMG) analyses were performed according to standard procedures at the Department of Clinical Neurophysiology, Uppsala (7). In short, surface electrodes were used to determine motor nerve conduction Inhibitors,research,lifescience,medical velocities, compound muscle action potential (CMAP) amplitudes, distal latencies and F-responses (median, ulnar, tibial, and peroneal nerves bilaterally) and sensory nerve conduction velocities and amplitudes (median, ulnar, radial and sural nerves bilaterally). Disposable concentric needle EMG needles were used (Medtronic, Copenhagen, Denmark) in the analyses of Levetiracetam spontaneous EMG activity, interference pattern, and quantitative motor unit potential measurements using the automatic Multi MUP analysis program. At least 20 motor unit potentials were analysed in each muscle (m. biceps brachii, m. extensor digitorum, m. see more vastus lateralis and m. tibialis anterior). The arm muscles were analysed on the right side and the leg muscles bilaterally. All measurements were performed using commercially available equipment (Keypoint, Medtronic).